This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Stella Aslanyan: Innovator in Inflammatory Disease Treatment
Introduction
Stella Aslanyan is a prominent inventor based in Danbury, CT (US). She has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases. Her innovative work focuses on utilizing anti-IL-23A antibodies to address various IL-23 related diseases.
Latest Patents
Stella holds a patent for her invention titled "Methods of treating inflammatory diseases." This patent relates to methods for the treatment of inflammatory conditions such as psoriasis, psoriatic arthritis, and axial spondyloarthritis, including ankylosing spondylitis and non-radiographic ax-SpA. Her groundbreaking approach aims to improve the quality of life for patients suffering from these debilitating conditions. She has 1 patent to her name.
Career Highlights
Stella is currently employed at Boehringer Ingelheim International GmbH, where she continues to advance her research in the pharmaceutical industry. Her work is characterized by a commitment to developing effective treatments for complex inflammatory diseases.
Collaborations
Stella collaborates with esteemed colleagues, including Matthias Arndt and Mary Ruth Flack. These partnerships enhance her research efforts and contribute to the development of innovative therapeutic solutions.
Conclusion
Stella Aslanyan's contributions to the field of inflammatory disease treatment exemplify her dedication to medical innovation. Her work not only advances scientific understanding but also holds the potential to significantly impact patient care.